Delve into Eli Lilly’s biopharma strategy as it advances its pipeline, wins regulatory milestones, and forges strategic deals ...

Novo Nordisk , looking to turn around slowing growth of its blockbuster weight-loss drug Wegovy, plans to test whether its ...

Eli Lilly's Orforglipron shows superior results in glycemic control and weight loss compared to oral semaglutide in recent ...

Elevance Health Inc. was hit with a proposed class action by a woman who says the insurer wrongly refuses to cover the weight-loss drug Zepbound for patients who need it to treat obstructive sleep ...

Medicare and Medicaid coverage of GLP-1 weight loss drugs could be just what the doctor ordered for these two struggling ...

A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer ...

Discover why LLY stock is rated Buy as sales surge in diabetes & obesity drugs and new treatments drive future growth.

A groundbreaking weight-loss pill made by the manufacturer of Mounjaro is expected to be available in the UK next year, the ...

Leveraging advanced 3D-printing technology and patented Vertex Technology, this device offers a custom-fit, patient-friendly ...

Medicare Part D beneficiaries experienced a large increase in out-of-pocket spending for GLP-1s in 2025, according to ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Inspire Medical Systems, ...